Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$194k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
5.9% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
1
users have commented on this narrative
30
users have followed this narrative
Updated
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
1.4% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
20
users have liked this narrative
12
users have commented on this narrative
26
users have followed this narrative
12 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
2.5% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
20
users have liked this narrative
7
users have commented on this narrative
25
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
44.5% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
15
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Aumann
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
E-mobility And Automation Will Unfold Mixed Future Results
Key Takeaways Aumann's focus on e-mobility and automation in high-growth industries is anticipated to drive significant revenue growth and enhance margins. Strategic investments and a strong balance sheet enable flexible growth via technology and market expansions, sustaining profitability and earnings.
View narrative
€13.90
FV
18.8% undervalued
intrinsic discount
-5.03%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
10 days ago
author updated this narrative
GCC. de
AN
AnalystConsensusTarget
Consensus Narrative from 10 Analysts
Upgraded Texas Cement Facilities Will Fuel Sustainable Progress
Key Takeaways Expansion of production capacity and cost optimization measures are set to strengthen margins and maintain growth despite industry volatility. Sustainability initiatives and involvement in large infrastructure projects support premium pricing and offer stable, long-term demand visibility.
View narrative
Mex$232.75
FV
25.0% undervalued
intrinsic discount
8.01%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
10 days ago
author updated this narrative
Medartis Holding
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
New CEO And Keri Touch Launch Will Accelerate US And LATAM Expansion
Key Takeaways The strategic initiatives under new leadership in the U.S. and LATAM, including product launches and acquisitions, aim to improve revenue and market share. Digital transformation and patient-specific innovation are expected to boost growth and competitive positioning, enhancing revenue and margins.
View narrative
CHF 89.47
FV
6.8% undervalued
intrinsic discount
16.39%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
10 days ago
author updated this narrative
Hikma Pharmaceuticals
AN
AnalystConsensusTarget
Consensus Narrative from 11 Analysts
US, Europe, And MENA Expansion Will Boost Global Pharmaceutical Demand
Key Takeaways Expanding global manufacturing and focus on complex generics position Hikma to benefit from rising pharmaceutical demand and the shift toward more cost-effective health solutions. Robust R&D, resilient MENA operations, and strong supply chain compliance provide higher-margin growth, stable performance amid regional volatility, and greater reliability than import-dependent peers.
View narrative
UK£25.09
FV
26.8% undervalued
intrinsic discount
5.92%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
21
users have followed this narrative
10 days ago
author updated this narrative
Dexco
AN
AnalystConsensusTarget
Consensus Narrative from 10 Analysts
Urbanization Trends And Digital Platforms Will Expand Market Reach
Key Takeaways Focus on higher-value products, operational efficiency, and digital expansion is enhancing profitability, revenue quality, and market reach. Strong sustainable practices and ESG positioning enable premium pricing and margin protection amid tightening industry regulations.
View narrative
R$8.25
FV
30.8% undervalued
intrinsic discount
4.57%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
10 days ago
author updated this narrative
Experian
AN
AnalystConsensusTarget
Consensus Narrative from 15 Analysts
Acquisitions Of Illion And ClearSale Will Strengthen Future Market Presence
Key Takeaways Strategic acquisitions and innovation in platforms like Ascend enhance Experian's market position, drive revenue growth, and improve net margins with new capabilities. Expanded product ecosystems and consumer engagement in high-demand markets drive strong revenue growth and earnings potential.
View narrative
UK£43.65
FV
11.4% undervalued
intrinsic discount
9.03%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
20
users have followed this narrative
10 days ago
author updated this narrative
Greencore Group
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Making Business Easier Program Will Streamline Operations And Improve Future Efficiency
Key Takeaways Operational excellence and technology transformation drive cost reductions, margin improvements, and enhanced future earnings potential through efficiency and standardization. Renewed contracts and product innovation underpin stable revenue growth and better pricing strategies, while a stronger balance sheet offers financial flexibility.
View narrative
UK£2.56
FV
0.1% undervalued
intrinsic discount
3.76%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
10 days ago
author updated this narrative
Renishaw
AN
AnalystConsensusTarget
Consensus Narrative from 9 Analysts
Neuro And Additive Manufacturing Investments Will Boost Future Prospects
Key Takeaways Strong semiconductor market performance and aerospace investments are expected to boost Renishaw's revenue and future growth. Strategic focus on emerging markets and innovative technologies aims to increase market share and enhance profitability.
View narrative
UK£31.30
FV
3.4% overvalued
intrinsic discount
4.94%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
9
users have followed this narrative
10 days ago
author updated this narrative
Volution Group
AN
AnalystConsensusTarget
Consensus Narrative from 7 Analysts
Acquisition Of Fantech Will Provide New Opportunities For Cross-Selling And Product Introductions
Key Takeaways The acquisition of Fantech strengthens Volution's market position in Australia and New Zealand, offering opportunities for revenue and margin enhancements. Emphasis on sustainability and management development aims to boost operational efficiency and capture customer demand, supporting potential earnings growth.
View narrative
UK£6.72
FV
2.9% undervalued
intrinsic discount
13.72%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
10 days ago
author updated this narrative
Value any company in seconds
Popular companies